Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice - PubMed (original) (raw)

. 2007 Dec;32(12):2132-41.

doi: 10.1007/s11064-007-9387-9. Epub 2007 Jun 12.

Affiliations

Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice

Ying Li et al. Neurochem Res. 2007 Dec.

Abstract

Recombinant human erythropoietin (rhEPO), a neurovascular protective agent, therapeutically supports angiogenesis after stroke by enhancing endogenous up-regulation of vascular endothelial growth factor (VEGF). Increased VEGF expression has been characterized to negatively impact the integrity of the blood brain barrier (BBB), causing brain edema and secondary injury. The present study investigated the rhEPO-induced BBB protection after stroke and how it might be achieved by affecting VEGF pathway. rhEPO treatment (5,000 U/kg, i.p., 30 min before stroke and once a day for three days after stroke) reduced Evans blue leakage and brain edema after ischemia. The expression of the BBB integrity markers, occludin, alpha-catenin and beta-catenin, in the brain was preserved in animals received rhEPO. rhEPO up-regulated VEGF expression; however, the expression of VEGF receptor-2 (fetal liver kinase receptor, Flk-1) was significantly reduced in rhEPO-treated animals three days after stroke. We propose that, disregarding increased VEGF levels, rhEPO protects against ischemia-induced BBB damage at least partly by down-regulating Flk-1 expression and the response to VEGF signaling in the acute phase after stroke.

PubMed Disclaimer

References

    1. Neurosurgery. 2004 Jan;54(1):131-40; discussion 141-2 -PubMed
    1. EMBO J. 1996 Jan 15;15(2):290-98 -PubMed
    1. Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H434-40 -PubMed
    1. Restor Neurol Neurosci. 2004;22(2):105-19 -PubMed
    1. Neurotoxicology. 2005 Oct;26(5):923-8 -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources